Detection and Delineation of Oral Cancer With a PARP1-Targeted Optical Imaging Agent
More sensitive and specific methods for early detection are imperative to improve survival rates in oral cancer. However, oral cancer detection is still largely based on visual examination and histopathology of biopsy material, offering no molecular selectivity or spatial resolution. Intuitively, th...
Main Authors: | Susanne Kossatz, Wolfgang Weber, Thomas Reiner |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2017-08-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.1177/1536012117723786 |
Similar Items
-
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
by: Ramya Ambur Sankaranarayanan, et al.
Published: (2020-07-01) -
DNA Repair Enzyme Poly(ADP-Ribose) Polymerase 1/2 (PARP1/2)-Targeted Nuclear Imaging and Radiotherapy
by: Nghia T. Nguyen, et al.
Published: (2022-02-01) -
Current Practice and Emerging Molecular Imaging Technologies in Oral Cancer Screening
by: Arianna Strome BS, et al.
Published: (2018-11-01) -
PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma
by: Sabrina Marcazzan, et al.
Published: (2024-02-01) -
Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
by: Dong Zhou, et al.
Published: (2021-05-01)